Correlation between in vitro and in vivo activity of amoxicillin against Streptococcus pneumoniae in a murine pneumonia model

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 310-315

  Moine, Pierre ^a,b   Mazoit, Jean Xavier ^a   Bédos, Jean Pierre ^b   Vallée, Éric ^b   Azoulay Dupuis, Esther ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Inst Natl de la S et de la R M   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN;

ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; BACTERICIDAL ACTIVITY; CORRELATION FUNCTION; DRUG EFFECT; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

AMOXICILLIN; ANIMALS; FEMALE; MICE; PENICILLINS; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0030893311     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ANDES D., URBAN, A. AND CRAIG, W. A.: In-vivo activity of amoxicillin and amoxicillin/clavulanate against penicillin-resistant pneumococci. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, A82, p 16, Annual Meeting of the American Society for Microbiology, San Francisco, CA, 1995.
2. AUSTRIAN, R.: Confronting drug-resistant pneumococci. Ann. Intern. Med. 121: 607-809, 1994.
3. AZOULAY-DUPUIS, E., BÉDOS, J. P., VALLÉE, E., HARDY, D. J., SWANSON, R. N. AND POCIDALO, J. J.: Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease. J. Infect. Dis. 163: 319-324, 1991.
4. BAKKER-WOUNDENBERG, I. A. J. M., VAN DEN BERG, J. C., FONTIJNE, P. AND MICHEL., M. F.: Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae in normal and immunodeficient rats. Eur. J. Clin. Microbiol. 3: 131-135, 1984.
5. BARZA, M.: A critique of animal models in antibiotic research. Scand. J. Infect. Dis. Suppl. 14: 109-117, 1978.
6. BÉDOS, J. P., ROLIN, O., BOUANCHAUD, D. H. AND POCIDALO, J. J.: Relation entre virulence et résistance aux antibiotiques des pneumocoques: Apport des données expérimentales sur un modèle animal. Pathol. Biol. 39: 984-990, 1991.
7. BERGERON, M. G.: A review of models for the therapy of experimental infections. Scand. J. Infect. Dis. Suppl. 14: 189-206, 1978.
8. BOSWELL, T. C., NYE, K. J. AND SMITH, E. G.: Penicillin- and penicillin-cephalosporin-resistant pneumococcal septicaemia. J. Antimicrob. Chemother. 34: 844-845, 1994.
9. BRILES, D. E., CRAIN, M. J., GRAY, B. M., FORMAN, C. AND YOTHER, J.: Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect. Immun. 60: 111-116, 1992.
10. FANTIN, B., LEGGETT, J., EBERT, S. AND CRAIG, W. A.: Correlation between in vitro and in vivo activity of antimicrobial agents against Gram-negative bacilli in a murine infection model. Antimicrob. Agents Chemother. 35: 1413-1422, 1991.
11. FINCH, R. G.: Penicillin-resistant pneumococci. Lancet 345: 457, 1995.
12. FRIMODT-MOLLER, N., BENTZON, M. W. AND THOMSEN, V. F.: Experimental infection with Streptococcus pneumoniae in mice: Correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. J. Infect. Dis. 154: 511-517, 1986.
13. FRIMODT-MOLLER, N., BENTZON, M. W. AND THOMSEN, V. F.: Experimental pneumococcus infection in mice: Comparative in vitro and in vivo effect of cefuroxime, cefotaxime and ceftriaxone. Acta Pathol. Microbiol. Immunol. Scand. 95: 261-267, 1987.
14. FRIMODT-MOLLER, N. AND THOMSEN, V. F.: The pneumococcus and the mouse-protection test: Correlation of in vitro and in vivo activity for beta-lactam antibiotics, vancomycin, erythromycin and gentamicin. Acta Pathol. Microbiol. Immunol. Scand. 95: 159-165, 1987.
15. GIBALDI, M. AND PERRIER, D.: Pharmacokinetics, 2nd ed., pp. 221-232, Marcel Dekker, New York, 1982.
16. HANDWERGER, S. AND TOMASZ, A.: Antibiotic tolerance among clinical isolates of bacteria. Rev. Infect. Dis. 7: 368-386, 1985.
17. HOLFORD, N.: MK MODEL: A Quantitative Modeling System for Pharmacologists, version 5, Biosoft, Cambridge, MA, 1994.
18. LEGGETT, J. E., FANTIN, B., EBERT, S., TOTSUKA, K., VOGELMAN, B., CALAME, W., MATTIE, H. AND CRAIG, W. A.: Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J. Infect. Dis. 159: 281-292, 1989.
19. LIU, H. H. AND TOMASZ, A.: Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. J. Infect. Dis. 152: 365-372, 1985.
20. MOINE, P., VALLÉE, E., AZOULAY-DUPUIS, E., BOURGET, P., BÉDOS, J. P., BAUCHET, J. AND POCIDALO, J. J.: In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 38: 1953-1958, 1994.
21. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A3, National Committee for Clinical Laboratory Standards, Villanova, PA, 1993.
22. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS: Performance Standards for Antimicrobial Susceptibility Testing: Document M100-56, National Committee for Clinical Laboratory Standards, Villanova, PA, 1995.
23. PALLARES, R., GUDIOL, F., LINARES, J., ARIZA, J., RUFI, G., MURGUI, I., DORCA, J. AND VILADRICH, P. F.: Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N. Engl. J. Med. 317: 18-22, 1987.
24. SCHMIDT, L. H. AND WALLEY, A.: The influence of the dosage regimen on the therapeutic effectiveness of penicillin G in experimental lobar pneumonia. J. Pharmacol. Exp. Ther. 103: 479-488, 1951.
25. SCHMIDT, L. H., WALLEY, A. AND LARSON, R. D.: The influence of the dosage regimen on the therapeutic activity of penicillin. J. Pharmacol. Exp. Ther. 96: 258-268, 1949.
26. TUOMANEM, E., DURACK, D. T. AND TOMASZ, A.: Antibiotic tolerance among clinical isolates of bacteria. Antimicrob. Agents Chemother. 30: 521-527, 1986.
27. VOGELMAN, B., GUDMUNDSSON, S., LEGGETT, J., TURNIDCJE, J., EBERT, S. AND CRAIG, W. A.: Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158: 831-846, 1988.
28. ZAK, O. AND SANDE, M. A.: Correlation of in vitro antimicrobial activity of antibiotics with results of treatment in experimental animal models and human infection. In Action of Antibiotics in Patients, ed. by L. D. Sabath, pp. 55-67, Hans Huber Publishers, Bern, Switzerland, 1982.